杂货巨头Albertsons第三季度销售增长,药品销售表现亮眼;上调年度盈利预期

财报速递
08 Jan
Albertsons Companies Inc(纽约证券交易所代码:ACI)周三盘前股价上涨,此前公司公布了第三季度财报。 公司的销售额同比增长1.2%,达到187.74亿美元,但低于分析师普遍预期的188.20亿美元。 这一增长主要是由同店销售增长2.0%所驱动,其中药品销售的强劲增长是同店销售增长的主要因素。同店销售增长2%,数字销售增长23%。 毛利率缩小10个基点至27.9%。本季度运营利润下降8%至5.185亿美元,营业利润率为2.8%。 调整后的息税折旧摊销前利润为10.65亿美元,同比下降3.7%。调整后的每股收益为0.71美元,高于分析师普遍预期的0.66美元。 截至11月30日,公司持有2.023亿美元的现金及等价物。40周的经营现金流总额为19.2亿美元。 2024年12月11日,董事会将季度现金股息从每普通股0.12美元增加25%至0.15美元。 今天,公司宣布将于2025年2月7日支付下一季度每股0.15美元的股息,股权登记日为2025年1月24日营业结束时。 截至2024年11月30日,包括融资租赁在内的总债务为78.4亿美元,净债务比率为1.88。 “我们的‘终身客户投资’战略推动了我们各平台的数字参与度的增加,数字销售、药房运营和忠诚度计划会员均实现了强劲增长,”首席执行官Vivek Sankaran表示。 12月,Albertsons宣布终止与Kroger Co的拟议合并。此前,美国一名法官阻止了该合并,理由是该交易将影响杂货领域的竞争。 展望:Albertsons将2024财年的调整后每股收益预期从2.20 – 2.30美元上调至2.25 – 2.31美元,分析师预期为2.26美元。 ACI预计2024财年的同店销售增长为1.8% – 2.0%(此前预期为1.8% – 2.2%)。 公司继续预计2024财年的资本支出为18亿美元至19亿美元。 股价表现:截至周三最后检查,ACI股价盘前上涨1.32%,至19.99美元。

以上内容来自Benzinga Earnings专栏,原文如下:

Albertsons Companies Inc (NYSE:ACI) shares are trading higher premarket on Wednesday after the company reported third-quarter earnings.

The company’s sales increased 1.2% year over year to $18.774 billion, missing the analyst consensus estimate of $18.820 billion.

The increase was driven by 2.0% increase in identical sales, with strong growth in pharmacy sales being the primary driver of the identical sales increase. Identical sales increased 2% and digital sales grew 23%.

Gross margin rate contracted 10 basis points to 27.9%. The operating margin was 2.8%, and operating income for the quarter declined 8% to $518.5 million.

Adjusted EBITDA of $1.065 billion decreased 3.7% Y/Y. Adjusted EPS of $0.71 beat the analyst consensus estimate of $0.66.

The company held $202.3 million in cash and equivalents as of November 30. Operating cash flow for 40 weeks totaled $1.92 billion.

On December 11, 2024, the Board of Directors increased the quarterly cash dividend by 25% from $0.12 per common share to $0.15 per common share.

Today, the company announced the next quarterly dividend payment of $0.15 per share to be paid on February 7, 2025, to stockholders of record as of the close of business on January 24, 2025.

Total debt, including finance leases, was $7.84 billion as of November 30, 2024. Net debt ratio was 1.88.

“Investments in our Customers for Life strategy drove increased digital engagement across our platforms, evidenced by strong growth in our digital sales, pharmacy operations, and membership in our loyalty program,” said CEO Vivek Sankaran.

In December, Albertsons announced the termination of its proposed merger with Kroger Co. The decision followed after a a U.S. judge blocked the proposed merger, citing that the deal would impact competition in the grocery space.

Outlook: Albertsons raised FY24 adjusted EPS outlook from $2.20 – $2.30 to $2.25 – 2.31 versus an estimate of $2.26.

ACI expects FY24 identical sales growth of 1.8% – 2.0% (previously 1.8% – 2.2%). 

The company continues to see FY24 capital expenditures of $1.8 billion to $1.9 billion.

Price Action: ACI shares are trading higher by 1.32% at $19.99 in premarket at the last check Wednesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10